Madrigal Pharmaceuticals
MDGL
84 hedge funds and large institutions have $249M invested in Madrigal Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 84 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
247% more call options, than puts
Call options by funds: $11.1M | Put options by funds: $3.21M
72.25% more ownership
Funds ownership: 0% → 72.25% (+72%)
Top Buyers
Top Sellers
MDGL Hedge Fund Activity: Q2 2013 in Review
84 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in Madrigal Pharmaceuticals (MDGL) for Q2 2013, worth a combined $249M.
Buyers outnumbered sellers: 84 funds opened new MDGL positions and 0 closed out — a net gain of 84 holders — while 0 added to existing stakes and 0 trimmed.
- 84 institutional investors held Madrigal Pharmaceuticals (MDGL) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $249M of Madrigal Pharmaceuticals stock for Q2 2013.
- 84 funds opened new Madrigal Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +84 holders.
Based on aggregated 13F filings for Q2 2013.